职位

Alnylam

Alnylam

Alnylam

Focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

RNA Interference

Gene Therapy

Drug Development

Biomedical Research

Cambridge, Massachusetts

501-1,000

2002年成立(第24年)

混合办公

Public

估值

$12.8B

融资总额

$3.2B

ALNY

$302.11

营收 (2026)

$0

营业利润

$0

Alnylam在招职位

0个在招职位

目前没有在招职位

产品与服务

ON

ONPATTRO (patisiran)

Marketed Drug

RN

RNAi Platform Technology

Technology Platform

AM

AMVUTTRA (vutrisiran)

Marketed Drug

OX

OXLUMO (lumasiran)

Marketed Drug

GI

GIVLAARI (givosiran)

Marketed Drug

Drug Development Services

Drug Development Services

Services

CE

Cemdisiran

Pipeline Drug

LE

LEQVIO (inclisiran)

Partnered Drug

AL

ALN-APP

Pipeline Drug

Fitusiran

Fitusiran

Pipeline Drug

AL

ALN-HBV02

Pipeline Drug

浏览量

0

申请点击

0

Mock Apply

0

收藏

0

评价

4.1

10条评价

工作生活平衡

2.8

薪酬

4.2

企业文化

4.0

职业发展

3.5

管理层

3.2

75%

推荐率

优点

Great benefits and health benefits

Collaborative team environment

Cutting-edge research and challenging projects

缺点

High workload and overwhelming demands

Work-life balance issues

Limited career advancement opportunities

薪资范围

69个数据点

Director

Intern

Mid/L4

Senior/L5

Director

1份报告

$231,400

年薪总额

基本工资

$178,000

股票

-

$231,400

$231,400

面试评价

3条评价

难度

3.0

/ 5

时长

2-5w

体验

正面 0%

中性 33%

负面 67%

面试流程

1

Application Review

2

HR Screen

3

Hiring Manager Interview

4

Panel Interview

5

Final Round Interview

6

Offer

联系方式与地址